cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.5517/ccdc.csd.cc2h3rds
title: CCDC 2297515: Experimental Crystal Structure Determination

description: Related Article: chen ming-hua|2023|CSD Communication|||
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2h3rft
title: CCDC 2297516: Experimental Crystal Structure Determination

description: Related Article: chen ming-hua|2023|CSD Communication|||
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.57841/casdc.0002552
title: 研磨子抑制高速列车车轮多边形磨耗的机理研究
DOI: 10.34740/kaggle/dsv/6544836
title: Egypt Gold Prices | Daily Updated
DOI: 10.5281/zenodo.8112807
title: Datasets of Binary language changes extracted from the CCLAMP corpus

description: Datasets which contain Dutch binary language changes, based on the C-CLAMP corpus. The corpus contains data from 1850 till 1999. For more information see also: https://github.com/julienijs/Predictability-of-language-change
DOI: 10.5281/zenodo.8112806
title: Datasets of Binary language changes extracted from the CCLAMP corpus

description: Datasets which contain Dutch binary language changes, based on the C-CLAMP corpus. The corpus contains data from 1850 till 1999. For more information see also: https://github.com/julienijs/Predictability-of-language-change
DOI: 10.5258/soton/d2792
title: Dataset supporting the publication "Effects of integral length scale variations on the stall characteristics of a wing at high freestream turbulence conditions"

description: This dataset is supporting the publication "Effects of integral length scale variations on the stall characteristics of a wing at high freestream turbulence conditions". To be published in Journal of Fluid Mechanics This dataset includes all the relevant data for the figures found within the paper in txt format. For enquiries please contact Craig Thompson: ct4g16@soton.ac.uk
DOI: 10.6084/m9.figshare.23592077
title: Nationwide analysis of survival after radical cystectomy for bladder cancer in Finland

description: Population-based survival results after radical cystectomy (RC) are limited. Our objective was to report short and long-term survival results after RC for bladder cancer from Finland in a population-based setting. The Finnish National Cystectomy Database containing retrospectively collected essential RC data covering the years 2005–2017 was combined with the survival data from the Finnish Cancer Registry. Kaplan-Meier plots were used to estimate survival and the survival graphs were illustrated according to the final pathological staging. Centers were divided according to operational volume, and the results were then compared using Pearsons’s Chi-squared test. A total of 2047 patients were included in the study. 30-, and 90-day mortality was 1.3%, and 3.8%, respectively. The OS of the entire RC population at 5- and 10 years was 66% and 55%, and CSS was 74% and 72%, respectively. Center volume did not significantly associate with surgical mortality or long-term survival. The 5- and 10-year OS according to pT-category was 87% and 74% for pT0, 85% and 69% for pTa-pTis-pT1, 70% and 58% for pT2, 50% and 42% for pT3 and 41% and 30% for pT4. The corresponding 5- and 10-year CSS rates were 96% and 93% for pT0, 91% and 90% for pTa-pTis-pT1, 78% and 75% for pT2, 56% and 55% for pT3 and 47% and 44% for pT4. The 5- and 10-year OS rates in patients with no lymph node metastases (pN-) were 74% and 62%, and CSS 82% and 80%, respectively. If lymph nodes were positive (pN+), the corresponding OS rates were 44% and 34% and CSS 49% and 48%, respectively. RC survival results have improved in contemporary series and are associated with the pTNM-status. The nationwide results from Finland demonstrate outcome comparable to high volume single-center series.
DOI: 10.6084/m9.figshare.23592077.v2
title: Nationwide analysis of survival after radical cystectomy for bladder cancer in Finland

description: Population-based survival results after radical cystectomy (RC) are limited. Our objective was to report short and long-term survival results after RC for bladder cancer from Finland in a population-based setting. The Finnish National Cystectomy Database containing retrospectively collected essential RC data covering the years 2005–2017 was combined with the survival data from the Finnish Cancer Registry. Kaplan-Meier plots were used to estimate survival and the survival graphs were illustrated according to the final pathological staging. Centers were divided according to operational volume, and the results were then compared using Pearsons’s Chi-squared test. A total of 2047 patients were included in the study. 30-, and 90-day mortality was 1.3%, and 3.8%, respectively. The OS of the entire RC population at 5- and 10 years was 66% and 55%, and CSS was 74% and 72%, respectively. Center volume did not significantly associate with surgical mortality or long-term survival. The 5- and 10-year OS according to pT-category was 87% and 74% for pT0, 85% and 69% for pTa-pTis-pT1, 70% and 58% for pT2, 50% and 42% for pT3 and 41% and 30% for pT4. The corresponding 5- and 10-year CSS rates were 96% and 93% for pT0, 91% and 90% for pTa-pTis-pT1, 78% and 75% for pT2, 56% and 55% for pT3 and 47% and 44% for pT4. The 5- and 10-year OS rates in patients with no lymph node metastases (pN-) were 74% and 62%, and CSS 82% and 80%, respectively. If lymph nodes were positive (pN+), the corresponding OS rates were 44% and 34% and CSS 49% and 48%, respectively. RC survival results have improved in contemporary series and are associated with the pTNM-status. The nationwide results from Finland demonstrate outcome comparable to high volume single-center series.
DOI: 10.6084/m9.figshare.23830976
title: 5-Year survival in Danish patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitor monotherapy

description: Convincing results from randomized controlled trials (RCTs) have led to increasing use of immune checkpoint inhibitors (ICI) as part of standard therapies in real-world (RW) scenarios. However, RW patients differ clinically from RCT populations and might have reduced long-term survival. Currently, only sparse data on 3-5-year survival rate for RW patients with advanced non-small cell lung cancer (NSCLC) treated with ICI exist. A multicenter study was performed including 729 patients with advanced NSCLC receiving monotherapy with ICI (retrospective data (<i>n</i> = 566) and prospective data (<i>n</i> = 163)). Detailed baseline clinical characteristics, programmed death-ligand 1 (PD-L1) tumor proportion score (TPS), and baseline haematological count were registered. Kaplan–Meier estimates and log-rank test were used for survival analyses, Cox regression for determination of prognostic factors. Median time of follow-up (FU) was 48.7 months (IQR 37.2–54.3). Median overall survival (OS) in first line treatment was 20.4 months (IQR 8.5–45.0) compared to 11.4 months (IQR 4.6–27.1) in ≥2nd line (HR 1.48, 95% CI 1.25–1.75). Estimated probability of OS was 30% at 3 years, 23% at 4 years, and 13% at 5 years in first line compared to 17, 13, and 11% in ≥2nd line, respectively. For those with performance status (PS) 2, the 2-year OS rate was 32% (95% CI 0.22–0.43) compared to 5% (95% CI 0.01–0.15) in patients with PD-L1 ≥ 50% versus &lt;50%, respectively. Compared to RCTs, long-term OS and PFS rates are lower in real-world patients treated with ICI in first line but much improved compared to historic rates on chemotherapy. A promising flattening of both the OS and progression free survival curves illustrates that also a subset of real-world patients obtain long-term remission. Patients with PS 2 and PD-L1 ≥ 50% may obtain clinically meaningful 2-year PFS and OS rates.
DOI: 10.6084/m9.figshare.23830976.v1
title: 5-Year survival in Danish patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitor monotherapy

description: Convincing results from randomized controlled trials (RCTs) have led to increasing use of immune checkpoint inhibitors (ICI) as part of standard therapies in real-world (RW) scenarios. However, RW patients differ clinically from RCT populations and might have reduced long-term survival. Currently, only sparse data on 3-5-year survival rate for RW patients with advanced non-small cell lung cancer (NSCLC) treated with ICI exist. A multicenter study was performed including 729 patients with advanced NSCLC receiving monotherapy with ICI (retrospective data (<i>n</i> = 566) and prospective data (<i>n</i> = 163)). Detailed baseline clinical characteristics, programmed death-ligand 1 (PD-L1) tumor proportion score (TPS), and baseline haematological count were registered. Kaplan–Meier estimates and log-rank test were used for survival analyses, Cox regression for determination of prognostic factors. Median time of follow-up (FU) was 48.7 months (IQR 37.2–54.3). Median overall survival (OS) in first line treatment was 20.4 months (IQR 8.5–45.0) compared to 11.4 months (IQR 4.6–27.1) in ≥2nd line (HR 1.48, 95% CI 1.25–1.75). Estimated probability of OS was 30% at 3 years, 23% at 4 years, and 13% at 5 years in first line compared to 17, 13, and 11% in ≥2nd line, respectively. For those with performance status (PS) 2, the 2-year OS rate was 32% (95% CI 0.22–0.43) compared to 5% (95% CI 0.01–0.15) in patients with PD-L1 ≥ 50% versus &lt;50%, respectively. Compared to RCTs, long-term OS and PFS rates are lower in real-world patients treated with ICI in first line but much improved compared to historic rates on chemotherapy. A promising flattening of both the OS and progression free survival curves illustrates that also a subset of real-world patients obtain long-term remission. Patients with PS 2 and PD-L1 ≥ 50% may obtain clinically meaningful 2-year PFS and OS rates.
DOI: 10.6084/m9.figshare.23741570
title: CBCT-based deformable dose accumulation of external beam radiotherapy in cervical cancer

description: <b>Background:</b> Delivered radiotherapy doses do not exactly match those planned for a course of treatment, largely due to inter-fraction changes in anatomy. In this study, accumulated delivered dose was calculated for a sample of cervical cancer patients, by deformably registering daily cone beam computed tomography (CBCT) images to the planning computed tomography (CT) scan. Planned and accumulated doses were compared for the clinical target volume (CTV), bladder, and rectum. <b>Material and Methods:</b> For 10 patients receiving 45 Gy in 25 fractions of external beam radiotherapy, daily dose distributions were calculated on CBCT. These images were deformed onto the planning CT and the dose was accumulated using Velocity 4.1 (Varian Medical Systems, Palo Alto, USA). The quality of deformable image registration was evaluated visually and by calculating Dice similarity coefficients and mean distance to agreement. <b>Results:</b> V95%&gt;99% was achieved for the primary CTV in 9/10 patients for the planned dose distribution and 7/10 patients for the accumulated dose distribution. Primary CTV coverage by 95% of the prescription dose was reduced in one patient, due to an increase in anterior-posterior separation. Comparison of planned and accumulated dose volume histograms (DVHs) for the bladder and rectum found agreement within 5% at low and intermediate doses, but differences exceeded 20% at higher doses. Direct addition of CBCT DVHs was seen to be a poor estimate for the accumulated DVH at higher doses. <b>Conclusion:</b> Computation of delivered radiotherapy dose that accounts for inter-fraction anatomical changes is important for establishing dose-effect relationships. Updating delivered dose distributions after each fraction would support informed clinical decision making on any potential treatment interventions.
DOI: 10.6084/m9.figshare.23741570.v1
title: CBCT-based deformable dose accumulation of external beam radiotherapy in cervical cancer

description: <b>Background:</b> Delivered radiotherapy doses do not exactly match those planned for a course of treatment, largely due to inter-fraction changes in anatomy. In this study, accumulated delivered dose was calculated for a sample of cervical cancer patients, by deformably registering daily cone beam computed tomography (CBCT) images to the planning computed tomography (CT) scan. Planned and accumulated doses were compared for the clinical target volume (CTV), bladder, and rectum. <b>Material and Methods:</b> For 10 patients receiving 45 Gy in 25 fractions of external beam radiotherapy, daily dose distributions were calculated on CBCT. These images were deformed onto the planning CT and the dose was accumulated using Velocity 4.1 (Varian Medical Systems, Palo Alto, USA). The quality of deformable image registration was evaluated visually and by calculating Dice similarity coefficients and mean distance to agreement. <b>Results:</b> V95%&gt;99% was achieved for the primary CTV in 9/10 patients for the planned dose distribution and 7/10 patients for the accumulated dose distribution. Primary CTV coverage by 95% of the prescription dose was reduced in one patient, due to an increase in anterior-posterior separation. Comparison of planned and accumulated dose volume histograms (DVHs) for the bladder and rectum found agreement within 5% at low and intermediate doses, but differences exceeded 20% at higher doses. Direct addition of CBCT DVHs was seen to be a poor estimate for the accumulated DVH at higher doses. <b>Conclusion:</b> Computation of delivered radiotherapy dose that accounts for inter-fraction anatomical changes is important for establishing dose-effect relationships. Updating delivered dose distributions after each fraction would support informed clinical decision making on any potential treatment interventions.
DOI: 10.5523/bris.3d1sge14ol61b2tfr4xyc37xti
title: Shape-Conformable Suction Cups

description: Included here are data to support the paper: Tianqi Yue, Hermes Bloomfield-Gadêlha and Jonathan Rossiter, Shape-Conformable Suction Cups for Adaptive Suction on Highly-curved Surfaces, IEEE Robotics and Automation Letters
DOI: 10.21944/sciamachy-surface-albedo
title: SCIAMACHY surface reflectivity climatology

description: The SCIAMACHY surface albedo database contains the Lambertian-equivalent reflectivity (LER) of the Earth's surface, derived from observations made by the SCIAMACHY satellite instrument, for each month of the year, for 34 wavelength bands ranging from 328 nm to 2314 nm. The spatial resolution of the database grid is 0.5 x 0.5 degrees but the real intrinsic spatial resolution is 1.0 x 1.0 degrees except near coastlines and for certain regions such as snow covered mountain ranges and the Sahara desert where it is 0.5 x 0.5 degrees. The reflectivity of the Earth's surface is an important input parameter for many satellite retrievals of atmospheric composition. The SCIAMACHY surface LER database was constructed to support satellite retrieval of trace gases and of cloud and aerosol information. The database is described in the following paper: L.G. Tilstra, O.N.E. Tuinder, P. Wang, and P. Stammes, Surface reflectivity climatologies from UV to NIR determined from Earth observations by GOME-2 and SCIAMACHY, J. Geophys. Res. Atmos. 122, 4084-4111, doi:10.1002/2016JD025940, 2017.
DOI: 10.5281/zenodo.8093520
title: Supplemental Information

description: <strong>Scatterplots of POPs for "Prenatal and early postnatal exposure to Persistent Organic Pollutants (POPs) – What is the correlation between Dioxins and long-chain Per- and Polyfluorinated Alkyl Substances (PFAS)?"</strong>
DOI: 10.5281/zenodo.8093521
title: Supplemental Information

description: <strong>Additional Scatterplots of POPs for "Prenatal and early postnatal exposure to Persistent Organic Pollutants (POPs) – What is the correlation between Dioxins and long-chain Per- and Polyfluorinated Alkyl Substances (PFAS)?"</strong>
DOI: 10.5281/zenodo.8305381
title: Supplemental Information

description: <strong>Additional Data and Scatterplots of POPs for "Prenatal and early postnatal exposure to Persistent Organic Pollutants (POPs) – What is the correlation between Dioxins and long-chain Per- and Polyfluorinated Alkyl Substances (PFAS)?"</strong>
DOI: 10.5281/zenodo.8379192
title: Supplemental Information

description: <strong>Scatterplots of POPs for "Prenatal and early postnatal exposure to Persistent Organic Pollutants (POPs) – What is the correlation between Dioxins and long-chain Per- and Polyfluorinated Alkyl Substances (PFAS)?"</strong>
DOI: 10.6084/m9.figshare.24197985
title: Data for Insights into the morphology, composition, and sources of atmospheric particulate matter on Mt. Qomolangma (Everest)

description: These files contain the data from the single particle sampling project on Mt. Qomalangma (Everest), comprising 52349 particles across 11 samples. They record the shape and composition data for each individual particle.
DOI: 10.5281/zenodo.7924755
title: The deflection of veel

description: A dataset about the deflection of <em>veel </em>in Dutch, based on the C-CLAMP corpus.
DOI: 10.5281/zenodo.7924754
title: The deflection of veel

description: A dataset about the deflection of <em>veel </em>in Dutch, based on the C-CLAMP corpus.
DOI: 10.6084/m9.figshare.24198311
title: Epidemiology, time course, and risk factors for hospital-acquired bloodstream infections in a cohort of 14,884 patients before and during the COVID-19 pandemic

description: COVID-19 pandemic has changed in-hospital care and was linked to superimposed infections. Here, we described epidemiology and risk factors for hospital-acquired bloodstream infections (HA-BSIs), before and during COVID-19 pandemic. This retrospective, observational, single-center real-life study included 14,884 patients admitted to hospital wards and intensive care units (ICUs) with at least one blood culture, drawn 48 h after admission, either before (pre-COVID, <i>N</i> = 7382) or during pandemic (<i>N</i> = 7502, 1203 COVID-19+ and 6299 COVID-19–). Two thousand two hundred and forty-five HA-BSI were microbiologically confirmed in 14,884 patients (15.1%), significantly higher among COVID-19+ (22.9%; <i>p</i><sub>trend</sub> &lt; .001). COVID-19+ disclosed a significantly higher mortality rate (33.8%; <i>p</i> &lt; .001) and more ICU admissions (29.7%; <i>p</i> &lt; .001). Independent HAI-BSI predictors were: COVID-19 (OR: 1.43, 95%CI: 1.21–1.69; <i>p</i> &lt; .001), hospitalization length (OR: 1.04, 95%CI: 1.03–1.04; <i>p</i> &lt; .001), ICU admission (OR: 1.38, 95%CI: 1.19–1.60; <i>p</i> &lt; .001), neoplasms (OR:1.48, 95%CI: 1.34–1.65; <i>p</i> &lt; .001) and kidney failure (OR: 1.81, 95%CI: 1.61–2.04; <i>p</i> &lt; .001). Of note, HA-BSI IRs for <i>Acinetobacter spp</i>. (0.16 × 100 patient-days) and <i>Staphylococcus aureus</i> (0.24 × 100 patient-days) peaked during the interval between first and second pandemic waves in our National context. Patients with HA-BSI admitted before and during pandemic substantially differed. COVID-19 represented a risk factor for HA-BSI, though not confirmed in the sole pandemic period. Some etiologies emerged between pandemic waves, suggesting potential COVID-19 long-term effect on HA-BSIs.
DOI: 10.6084/m9.figshare.24198311.v1
title: Epidemiology, time course, and risk factors for hospital-acquired bloodstream infections in a cohort of 14,884 patients before and during the COVID-19 pandemic

description: COVID-19 pandemic has changed in-hospital care and was linked to superimposed infections. Here, we described epidemiology and risk factors for hospital-acquired bloodstream infections (HA-BSIs), before and during COVID-19 pandemic. This retrospective, observational, single-center real-life study included 14,884 patients admitted to hospital wards and intensive care units (ICUs) with at least one blood culture, drawn 48 h after admission, either before (pre-COVID, <i>N</i> = 7382) or during pandemic (<i>N</i> = 7502, 1203 COVID-19+ and 6299 COVID-19–). Two thousand two hundred and forty-five HA-BSI were microbiologically confirmed in 14,884 patients (15.1%), significantly higher among COVID-19+ (22.9%; <i>p</i><sub>trend</sub> &lt; .001). COVID-19+ disclosed a significantly higher mortality rate (33.8%; <i>p</i> &lt; .001) and more ICU admissions (29.7%; <i>p</i> &lt; .001). Independent HAI-BSI predictors were: COVID-19 (OR: 1.43, 95%CI: 1.21–1.69; <i>p</i> &lt; .001), hospitalization length (OR: 1.04, 95%CI: 1.03–1.04; <i>p</i> &lt; .001), ICU admission (OR: 1.38, 95%CI: 1.19–1.60; <i>p</i> &lt; .001), neoplasms (OR:1.48, 95%CI: 1.34–1.65; <i>p</i> &lt; .001) and kidney failure (OR: 1.81, 95%CI: 1.61–2.04; <i>p</i> &lt; .001). Of note, HA-BSI IRs for <i>Acinetobacter spp</i>. (0.16 × 100 patient-days) and <i>Staphylococcus aureus</i> (0.24 × 100 patient-days) peaked during the interval between first and second pandemic waves in our National context. Patients with HA-BSI admitted before and during pandemic substantially differed. COVID-19 represented a risk factor for HA-BSI, though not confirmed in the sole pandemic period. Some etiologies emerged between pandemic waves, suggesting potential COVID-19 long-term effect on HA-BSIs.
DOI: 10.6084/m9.figshare.24198373
title: The lower Cambrian Cranbrook Lagerstätte of British Columbia

description: Supplementary Table 1.
DOI: 10.6084/m9.figshare.24198373.v1
title: The lower Cambrian Cranbrook Lagerstätte of British Columbia

description: Supplementary Table 1.
DOI: 10.6084/m9.figshare.24198385
title: The lower Cambrian Cranbrook Lagerstätte of British Columbia

description: Supplementary Tables 2 and 3.
DOI: 10.6084/m9.figshare.24198385.v1
title: The lower Cambrian Cranbrook Lagerstätte of British Columbia

description: Supplementary Tables 2 and 3.
DOI: 10.17909/cv44-c816
title: Data from paper
DOI: 10.5281/zenodo.8379225
title: Eastern DRC boundaries and ASM sites

description: Initial input dataset
DOI: 10.5281/zenodo.8379224
title: Eastern DRC boundaries and ASM sites

description: Initial input dataset
DOI: 10.57841/casdc.0002553
title: 碳纤维的长度与取向对聚醚醚酮基复合材料摩擦磨损性能的影响